Device therapy for spinal tumors that have stopped responding to treatment
Part of Cancer clinical trials.
This trial tests a wearable device that puts low-intensity electric fields on the skin over spinal tumors to slow their growth. It's for people whose spinal metastases have already been treated with surgery and/or radiation and have no more radiation options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one or more spinal tumors that were previously treated with surgery or maximum radiation, and no more standard radiation treatments are available.
- You are at least 22 years old.
- You are able to independently disconnect the device or turn it off if it gets too hot.
- You agree to wear the device for at least 18 hours per day and to follow all study visits.
- For those not having surgery, your doctor expects you to live more than 8 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special type of proton radiation for people whose spine cancer has spread from another part of the body and cannot be treated effectively with standard X-ray radiation. The goal is to see if proton radiation can safely deliver a high dose of radiation to the tumor.
This trial tests a wearable device called Tumor Treating Fields (TTF) combined with targeted radiation (stereotactic radiosurgery) for people with newly diagnosed brain metastases from non-small cell lung cancer. The goal is to see if the electric fields from the device can help control the brain tumors along with the radiation.
This trial tests whether Tumor Treating Fields (a non-surgical device that delivers treatment signals to cancer cells through the scalp/skin) can help people whose breast or lung cancer has spread into the fluid around the spine and brain. It focuses on people who have cancer cells found in spinal fluid and can safely use the device most of the day.
This trial tests a procedure where tiny radioactive seeds are placed into spinal tumors to relieve pain and control growth. It is for people with cancer that has spread to the bone and who are able to undergo the procedure safely.
This trial tests adding a device that delivers electric fields (Tumor Treating Fields) to standard immunotherapy and chemotherapy for people with advanced non-small cell lung cancer that has not been treated before. It may help slow tumor growth.
This trial tests a wearable device (TTFields) combined with a specific chemotherapy (mFOLFIRINOX) for people whose pancreatic cancer has spread to the liver and other organs. The device sends gentle electrical fields to disrupt cancer cell growth, and the chemo attacks cancer cells throughout the body.
Hear when a new Spinal Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.